UPDATE: Japan pins international competitiveness hopes on early practical application plan for 'pioneering' drugs and devices
This article was originally published in SRA
Executive Summary
Japan has announced ambitious new plans to speed up the development and evaluation of locally developed innovative pharmaceuticals, medical devices and regenerative medicines1. The plans involve prioritized review at the Pharmaceuticals and Medical Devices Agency with a reduction in the overall review period for such products from one year to six months.